neuroprotection, access-site management, and standardized endpoint reporting, will progressively refine best practices and improve outcomes for patients who require alternativeaccess TAVI.
Sobczyński et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: